Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR) as an Inflammatory Markers to Predict Length of Hospital Stay After Total Laparoscopic Hysterectomy (TLH) for Benign Indications
NCT ID: NCT05003297
Last Updated: 2021-08-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2014-01-01
2018-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inflammatory Markers in Natural Orifice Hysterectomies
NCT04221308
Inflammatory Markers in Hysterectomies
NCT04184765
Long Term Outcomes Following Total Laparoscopic Hysterectomy and Laparoscopic Supracervical Hysterectomy
NCT01289314
Postoperative CRP Levels and Vaginal Cuff Hematoma
NCT03879499
A Research on Hidden Blood Loss in Open Radical Hysterectomy and Pelvic Lymphadenectomy
NCT03628118
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients whom were hospitalized for 3 days or less
hemogram inflammatory parameters
Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR)
patients hospitalized for more than 3 days
hemogram inflammatory parameters
Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
hemogram inflammatory parameters
Neutrophil to Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Bladder injury,
* Bowel injury,
* Superficial inferior mesenteric artery injury
* Vaginal cuff hematoma
* Vaginal cuff dehiscence
* Endometriosis
* Endometrial cancer
* Cervical cancer
* Chronic lymphocytic leukemia
* Behçet disease
* Electrolyte imbalance
* Thyroid disease
* Using anti-inflammatory medications
* Having severe intraabdominal adhesions
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gaziosmanpasa Research and Education Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fatma ketenci gencer
Dr.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GaziosmanpasaTREHd
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.